Medical Evidence & Clinical Frameworks for TRT
Guideline-based information to support informed conversations with a licensed clinician.
Slide 1 of 3
Evidence-Informed Care
TRT National provides educational information and facilitates clinician-guided telemedicine where services are available, with a focus on hormone, metabolic-health, and related services that require individualized clinical review. Medical decisions should be based on current evidence, individual history, appropriate testing, and shared decision-making.
Prescription testosterone is a regulated medical treatment for appropriately diagnosed patients. Clinician-directed care may include baseline evaluation and follow-up monitoring; it does not guarantee eligibility, a prescription, or a risk-free outcome.
Clinical References
Established Clinical Guidelines for Hormone Replacement
Guidelines from the Endocrine Society and American Urological Association provide clinical frameworks for diagnosis, treatment selection, contraindications, and monitoring. Individual evaluation, current evidence, and product labeling remain essential.
Endocrine Society Clinical Practice Guideline
Diagnosis, treatment selection, contraindications, and monitoring for men with hypogonadism.
Read the guidelineAmerican Urological Association Testosterone Deficiency Guideline
Evaluation and management guidance for testosterone deficiency.
Read the guidelineFDA Testosterone Information
Current FDA information on approved uses, formulations, and June 2026 labeling updates.
Read FDA informationFDA Compounding Information
Regulatory information about compounded drugs and their safety, effectiveness, and quality limitations.
Read FDA compounding Q&AGlobal Consensus: Testosterone Therapy for Women
Evidence-based limits and monitoring considerations for testosterone therapy in women.
Read the consensus statementEndocrine Society 2026 TRT Statement
Current perspective on accurate diagnosis, reversible contributors, treatment risks, and evidence gaps.
Read the 2026 statementSupervised Treatment Reduces Risk, but Does Not Eliminate It
Unregulated or illicit products can add risks related to uncertain identity, potency, contamination, and absent clinical oversight. Prescription testosterone also has potential risks and contraindications, so diagnosis, shared decision-making, and monitoring remain important.
Clinician-supervised care and dispensing through an appropriately licensed pharmacy can reduce some avoidable risks, but they cannot make treatment risk-free.
Clinically Indicated Monitoring
Clinicians may reassess testosterone, hematocrit, blood pressure, symptoms, adverse effects, and other measures based on medical history, formulation, current guidance, and product labeling.
Individualized Formulation and Dose
The formulation and dose depend on the diagnosis, product instructions, laboratory results, clinical response, adverse effects, fertility goals, and clinical judgment. There is no universal testosterone dose.
Product Quality and Compounded-Drug Disclosure
Unregulated products may have identity, potency, or contamination problems. FDA-approved products undergo premarket review. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness, or quality before marketing; purity or sterility must not be guaranteed.
Testosterone Considerations Across Populations
Biological Foundations of Low Testosterone
Testosterone levels can vary with age, obesity, sleep disorders, acute or chronic illness, medications, and other factors. Symptoms are nonspecific, and a laboratory result by itself does not establish hypogonadism or determine that testosterone therapy is appropriate.
Testicular disorders and pituitary or hypothalamic conditions can disrupt hormone production. A clinician may use history, examination, and appropriate testing to distinguish possible causes, but one consultation cannot always identify a single mechanism.
Testosterone Therapy Considerations for Women
Evaluation and treatment for women should not be presented as equivalent to testosterone replacement for men. The principal evidence-based indication is hypoactive sexual desire disorder in appropriately assessed postmenopausal women. U.S. use is off-label, long-term safety remains uncertain, and current evidence does not support broad claims for cognition, metabolic rate, body composition, emotional stability, or general wellbeing.
Comparative Analysis of Testosterone Delivery Methods
Testosterone is available in several formulations. Route selection can affect application, pharmacokinetics, convenience, precautions, and monitoring; no route is best for everyone. Selection should be individualized according to the diagnosis, product-specific benefits and risks, fertility plans, patient preference, access, and clinical judgment.
Injectable Testosterone
Established prescription option | Product-specific route and interval | Monitoring required
Injectable formulations use different routes and dosing intervals. Blood levels may rise and fall between doses, so the exact product, schedule, follow-up testing, symptoms, and adverse effects should guide adjustment. Injections are not a universal gold standard.
Transdermal Creams
Often daily application | Product status varies | Transfer precautions may apply
Some testosterone creams are compounded rather than FDA-approved. Application schedules, absorption, and transfer precautions are product-specific. Patients should follow the prescribing instructions and avoid unintended exposure to partners or children.
Transdermal Gels, Solutions, and Patches
Product-specific topical schedule | Absorption and skin reactions vary | Prevent secondary exposure
Transdermal products can avoid injections. Absorption and skin reactions vary, and some gels or solutions can transfer to another person unless product-label application, drying, covering, and hand-washing precautions are followed.
Oral, Nasal, and Buccal Products
Non-injection formulations exist | Product-specific dosing | Individual safety requirements
Non-injection products can include oral, nasal, and buccal formulations. Approval status, dosing, administration, interactions, and safety requirements are product-specific; these routes should not be described as ineffective as a class.
The TRT National Onboarding Process
Where services are available, the process may include a secure intake, clinician-directed testing, consultation, and follow-up. Submission does not guarantee eligibility, treatment, a prescription, or shipment.
Digital Health Assessment
Complete a secure medical-history and symptom intake, including medications, health goals, and relevant history.
Diagnostic Evaluation
A clinician determines whether laboratory testing or other evaluation is medically appropriate. Available testing locations and required markers vary.
Licensed-Clinician Consultation
When eligible, meet an appropriately licensed clinician to review history, results, alternatives, fertility goals, possible benefits, risks, and state eligibility.
Prescription, Dispensing, and Follow-Up
If treatment is prescribed, medication may be dispensed or shipped by an appropriately licensed pharmacy and follow-up is scheduled. Product type, compounded status, service, and shipping remain subject to clinical judgment, pharmacy coverage, and state availability.
Frequently Asked Questions
What determines a testosterone dose?
There is no universal dose. The prescribed product, diagnosis, laboratory results, clinical response, adverse effects, fertility goals, and product-specific instructions all matter. Doses should be changed only by the treating clinician.
Can nutrition or lifestyle changes affect low testosterone?
Sleep, weight management, physical activity, alcohol use, medications, and treatment of underlying conditions can affect testosterone in some people. Lifestyle measures do not replace a medical evaluation, and testosterone therapy is not automatically required for every low result.
How often are testosterone injections given?
Frequency depends on the exact formulation, route, prescription, laboratory response, symptoms, and tolerability. A once-weekly schedule is not a universal standard.